Featured Research

from universities, journals, and other organizations

Radiation And Chemotherapy Before Surgery Effective In Fight Against Rectal Cancer

Date:
May 17, 1999
Source:
University of Florida
Summary:
The killing power of rectal cancer can be reduced sharply through a combination of radiation and drug therapy before surgery, University of Florida researchers report this month in the Annals of Surgery.

By Victoria White

GAINESVILLE, Fla.---The killing power of rectal cancer can be reduced sharply through a combination of radiation and drug therapy before surgery, University of Florida researchers report this month in the Annals of Surgery.

The approach also substantially decreases the likelihood that sufferers will have to endure one unpleasant side effect: a permanent colostomy, an artificial opening in the large intestine to allow the body to evacuate waste.

“Many tumors shrink in size dramatically with the combination therapy,” said Dr. Edward M. Copeland III, chairman of the department of surgery in UF’s College of Medicine. “We found that by adding chemotherapy to radiation, we could completely eliminate cancer cells in more of our patients before even going into surgery.

“The downstaging of the tumors also allows us to remove less tissue during surgery. This makes it easier to preserve the body’s normal waste elimination system.”

Rectal cancer strikes an additional 36,000 people each year in the United States, with an annual death rate of 8,800. It claims more victims than it has to: A report earlier this year by the U.S. Centers for Disease Control says that more than half of adults 50 and older fail toundergo the recommended screening tests to detect rectal or colon cancer, which together kill more than 55,000 people each year. The report suggests embarrassment, ignorance and fear of discomfort are partially to blame.

For decades, surgical removal of rectal cancer had been the recommended treatment. In the mid-1970s, UF physicians at Shands at UF medical center became among the first to use preoperative radiation to try to shrink some tumors to make them easier to remove. In 1991, UF physicians added the chemotherapy agent 5-flourouricil to the preoperativetherapy. Later, they added a second drug, leucovorin, to the treatment.

“We are not the only physicians to have tried this combination pre-surgical approach, but because we have been using preoperative radiation therapy as long as anyone in the world, we have a largedatabase of patients we can study,” said Copeland, who is the Edward R. Woodward professor of surgery.

Other major participants in the research included Dr. William M. Mendenhall, a professor of radiation oncology; Dr. Robert A. Zlotecki, anassociate professor of radiation oncology; and Dr. Robert D. Marsh, an associate professor of medicine.

The UF team compared outcomes for 219 people treated during the radiation and surgery era of 1975 to 1990 with 109 people treated from 1991 to 1997 whose therapy included the addition of preoperative chemotherapy. The patients all had locally advanced rectal cancer; some also had cancer spread to the lymph nodes.

The more recent group did better in several ways: For 28 percent, the pre-surgical therapy alone was enough to eliminate signs of cancer, compared with 8 percent in the earlier era.

Five-year survival rates also were expected to be higher in the radiation and chemotherapy group: an anticipated 87 percent vs. 58 percent. The rates are actuarial estimates based on the higher two-year survival rate of the group that received preoperative radiation andchemotherapy.

“Local recurrence of the cancer was about the same in both groups,” Copeland said. “The addition of chemotherapy to the treatment appears to have increased survival by reducing spread of the cancer to other parts of the body.”

Only 13 percent of patients in the combination group required a permanent colostomy following rectal cancer surgery, compared with 52 percent of the others. This difference between the two groups can be attributed to improved surgical techniques as well as the change intherapy, Copeland said.

“Our research suggests that preoperative radiation and chemotherapy is a promising approach for increasing survival,” Copeland said. “Our data potentially can be a springboard to theinitiation of large randomized clinical trials, which would provide a higher standard of scientific evidence.”

Dr. Kirby I. Bland, chairman of surgery at Brown University School of Medicine, called the research “an important advance for the surgical and oncological communities."

“The premiere institutions have been using preoperative radiation andchemotherapy, but UF got a jump on the international community with datademonstrating its worth in this population,” said Bland, a former UFprofessor who participated in the early studies.

-----------------------------------------

Recent UF Health Science Center news releases are available at http://www.health.ufl.edu/hscc/index.html


Story Source:

The above story is based on materials provided by University of Florida. Note: Materials may be edited for content and length.


Cite This Page:

University of Florida. "Radiation And Chemotherapy Before Surgery Effective In Fight Against Rectal Cancer." ScienceDaily. ScienceDaily, 17 May 1999. <www.sciencedaily.com/releases/1999/05/990514093804.htm>.
University of Florida. (1999, May 17). Radiation And Chemotherapy Before Surgery Effective In Fight Against Rectal Cancer. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1999/05/990514093804.htm
University of Florida. "Radiation And Chemotherapy Before Surgery Effective In Fight Against Rectal Cancer." ScienceDaily. www.sciencedaily.com/releases/1999/05/990514093804.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins